These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2396194)

  • 1. Intraperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.
    Archer S; Gray B
    Surgery; 1990 Sep; 108(3):502-7. PubMed ID: 2396194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental study on intraperitoneal sequential MTX/5-FU therapy for peritoneal seeding in comparison with intravenous administration].
    Maruyama M; Takamatsu S; Sugano N; Ebuchi M; Endo M; Yuasa Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2131-6. PubMed ID: 9388524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique.
    Oman M; Tölli J; Naredi P; Hafström LO
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
    Gerard A; Pector JC; Bleiberg H
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of portal vein chemotherapy with hepatic artery chemotherapy in the treatment of liver micrometastases.
    Archer SG; Gray BN
    Am J Surg; 1990 Mar; 159(3):325-9. PubMed ID: 2305941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of the 5-year survivor of ascending colon cancer associated with synchronous multiple liver metastasis and peritoneal dissemination successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
    Mochizuki R; Gunji Y; Takayama W; Miyazaki S; Makino H; Matsushita K; Miyauchi H; Chiba S; Ochiai T
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1662-4. PubMed ID: 15553676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer].
    Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ
    Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil plus leucovorin as adjuvant treatment of an experimental liver tumor in rats.
    Carlsson G; Gustavsson BG; Spears CP; Hafström LO
    Anticancer Res; 1990; 10(3):813-6. PubMed ID: 2369095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal 5-fluorouracil in the management of colorectal liver cancer.
    Andersson R; Holmberg A
    Eur J Surg Oncol; 1992 Apr; 18(2):152-5. PubMed ID: 1374724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study on intraperitoneal administration of 5-fluorouracil for liver metastasis in comparison with intravenous administration].
    Maruyama M; Sugano N; Ebuchi M; Yuasa Y
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):497-502. PubMed ID: 10097746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
    Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
    BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer.
    Sugarbaker PH; Gianola FJ; Speyer JC; Wesley R; Barofsky I; Meyers CE
    Surgery; 1985 Sep; 98(3):414-22. PubMed ID: 3898450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer.
    Almersjö O; Gustavsson B; Hafström L
    Ann Chir Gynaecol; 1976; 65(1):27-32. PubMed ID: 1032874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cisplatin/5-fluorouracil intraperitoneal administration superior to intravenous administration for liver metastases of colonic carcinoma].
    Maruyama M; Kudo T; Kuwahara H; Takamatsu S; Sugano N; Ebuchi M
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):2011-4. PubMed ID: 9350251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An experimental study on portal infusion of 5-fluorouracil].
    Ishida H; Iwama T; Nishioka Y; Endo S; Okubo Y; Imajo M; Otomo M; Mishima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1884-8. PubMed ID: 1877831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
    Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
    Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetastatic intraoperative chemotherapy of human colon tumors in the livers of nude mice.
    Rashidi B; An Z; Sun FX; Moossa AR; Hoffman RM
    Clin Cancer Res; 2000 Jun; 6(6):2464-8. PubMed ID: 10873100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of regional portal infusion of 5-fluorouracil in patients with primary and secondary liver cancer.
    Almersjo O; Gustavsson B; Hafström L
    Ann Chir Gynaecol Suppl; 1976; 65(1):27-32. PubMed ID: 1267405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
    Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
    J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.